Hypopharyngeal cancer other imaging findings
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2], Faizan Sheraz, M.D. [3]
Overview
Other diagnostic studies for hypopharyngeal cancer include Fluoro-D-glucose positron emission tomography (PET)-CT which shows increased uptake of tumor metabolic cells. Fluoro-D-glucose positron emission tomography (PET)-CT may be performed to detect late stages of hypopharyngeal cancer and inaccessible regions by endoscopy. Endoscopy can be useful in detecting primary tumor invasion and biopsy.
Other Imaging Findings
Positron Emission Tomography
- Fluoro-D-glucose positron emission tomography (PET)-CT shows increased uptake of tumor metabolic cells. Fluoro-D-glucose positron emission tomography (PET)-CT may be performed to detect late stages of hypopharyngeal cancer and inaccessible regions by endoscopy.[1][2]
Endoscopy
References
- ↑ Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ (March 2010). “(18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma”. Head Neck. 32 (3): 319–25. doi:10.1002/hed.21184. PMID 19626642.
- ↑ 2.0 2.1 Pracy, P; Loughran, S; Good, J; Parmar, S; Goranova, R (2016). “Hypopharyngeal cancer: United Kingdom National Multidisciplinary Guidelines”. The Journal of Laryngology & Otology. 130 (S2): S104–S110. doi:10.1017/S0022215116000529. ISSN 0022-2151.
- ↑ 3.0 3.1 3.2 Case courtesy of Dr Frank Gaillard, Radiopaedia.org, rID: 8891. http://radiopaedia.org/articles/hypopharyngeal-squamous-cell-carcinoma
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH